Trustedge Capital Cancels and Regrants 24,967 Employee Stock Options Under TEDGE ESOS 2025

2 min read     Updated on 12 May 2026, 08:14 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Trustedge Capital Limited's Nomination and Remuneration Committee, at its meeting on May 12, 2026, cancelled 24,967 unvested stock options under TEDGE ESOS 2025 following an employee's resignation, and subsequently approved a fresh grant of 24,967 stock options to eligible employees on the same date. Each option is convertible into one equity share at a face value of ₹ 10/- each, granted at face value in compliance with SEBI (SBE) Regulations, 2021. Vested options are exercisable within 5 years from the date of vesting, and the cancelled options have been returned to the option pool for future grants.

powered bylight_fuzz_icon
40142653

*this image is generated using AI for illustrative purposes only.

The Nomination and Remuneration Committee of Trustedge Capital Limited (formerly known as Adinath Exim Resources Limited) convened a meeting on May 12, 2026, and passed resolutions approving two key actions under the Trustedge Employee Stock Option Scheme 2025 (TEDGE ESOS 2025): the cancellation of unvested stock options and a fresh grant of stock options to eligible employees. The company made this disclosure to BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Cancellation of Unvested Stock Options

The committee took note of the cancellation of 24,967 unvested stock options that had been previously granted to an employee under the TEDGE ESOS 2025. The cancellation was triggered by the resignation of the employee to whom the options were originally granted. As per the terms of the scheme, the cancelled options have been added back to the option pool and will be available for future grants in accordance with applicable laws.

Parameter: Details
Scheme Name: Trustedge Employee Stock Option Scheme 2025 (TEDGE ESOS 2025)
Total Options Cancelled: 24,967
Reason for Cancellation: Resignation of the employee to whom options were granted
Status of Cancelled Options: Added back to the option pool for future grants

Fresh Grant of Stock Options

Following the cancellation, the Nomination and Remuneration Committee approved the grant of 24,967 stock options to eligible employees under the TEDGE ESOS 2025, with an effective grant date of May 12, 2026. Each option is convertible into one equity share of the company at a face value of ₹ 10/- each. The options have been granted at face value, i.e., ₹ 10, pursuant to the applicable provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Parameter: Details
Options Granted: 24,967
Effective Grant Date: May 12, 2026
Face Value per Share: ₹ 10/-
Total Shares Covered: 24,967 equity shares of face value ₹ 10/- each
Pricing Formula: Face value, i.e., ₹ 10
Exercise Period: Within 5 years from the date of vesting, or such other period as determined by the Committee
Scheme Compliance: SEBI (SBE) Regulations, 2021

Key Terms of TEDGE ESOS 2025

The TEDGE ESOS 2025 is administered by the Nomination and Remuneration Committee. The scheme outlines the following significant terms:

  • Objective: To align the interests of employees with the long-term goals of the company by offering them an opportunity to become shareholders.
  • Purpose: Designed to compensate and recognize performance, attract and retain talent, and drive future growth.
  • Grant Basis: Options shall be granted based on one or more pre-defined performance conditions as determined by the Committee.
  • Exercise Window: Vested options may be exercised anytime within the exercise window(s) as intimated by the company, provided it is within a period of 5 years from the date of vesting or such other period as determined by the Committee. All vested options can be exercised by the option grantee at one time within the exercise period.

The disclosure, along with Annexure-A containing details as required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, has been uploaded on the company's website. The intimation was signed by Manoj S. Savla, Chairman & Managing Director of Trustedge Capital Limited.

Historical Stock Returns for Trustedge Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%-4.55%+2.60%+80.46%+238.43%+3,231.33%

How might Trustedge Capital's decision to grant options at face value (₹10) rather than market price impact employee retention and the company's ability to attract senior talent compared to industry peers?

Given that the entire cancelled option pool was immediately re-granted to new eligible employees, what does this suggest about the company's talent acquisition strategy and pipeline under its rebranding from Adinath Exim Resources?

How could the 5-year exercise window post-vesting under TEDGE ESOS 2025 influence the potential dilution of existing shareholders' equity as the company scales its operations?

Trustedge Capital Confirms Full Compliance in Rights Issue Fund Utilisation for Q4 FY26

2 min read     Updated on 12 May 2026, 08:01 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Trustedge Capital Limited confirmed no deviation or variation in the utilisation of Rs. 2699.54 lakhs raised through its Rights Issue on October 17, 2025, for the quarter ended March 31, 2026. All three fund utilisation objects — augmenting capital base for onward lending (Rs. 1988.00 lakhs), General Corporate Purposes (Rs. 673.15 lakhs), and issue-related expenses (Rs. 38.39 lakhs) — were fully utilised as originally allocated. CARE Ratings Limited served as the monitoring agency, and the filing was made pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
40141854

*this image is generated using AI for illustrative purposes only.

Trustedge Capital Limited (formerly known as Adinath Exim Resources Limited) has filed a statement of deviation or variation in the utilisation of funds raised through its Rights Issue, as required under Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing, submitted on May 12, 2026, pertains to the quarter ended March 31, 2026, and confirms that there was no deviation or variation in the use of proceeds from the objects stated in the Letter of Offer dated September 25, 2025.

Rights Issue Fund Utilisation Overview

The company raised Rs. 2699.54 lakhs through its Rights Issue of Equity Shares, with funds received on October 17, 2025. The amount received on application was also Rs. 2699.54 lakhs. CARE Ratings Limited has been designated as the monitoring agency for the utilisation of these funds. The key details of the Rights Issue are summarised below:

Parameter: Details
Mode of Fund Raising: Rights Issue
Date of Raising Funds: October 17, 2025
Amount Raised: Rs. 2699.54 lakhs
Amount Received on Application: Rs. 2699.54 lakhs
Report Filed for Quarter Ended: March 31, 2026
Monitoring Agency: CARE Ratings Limited
Deviation / Variation in Use of Funds: No

Object-Wise Fund Utilisation

The funds raised through the Rights Issue were allocated across three distinct objects, all of which have been fully utilised as per the original allocation. No modifications were made to any of the original objects, and no deviation or variation was recorded for the quarter. The detailed object-wise utilisation is presented below (Rs. in Lakhs):

Original Object: Original Allocation Funds Utilised Deviation / Variation
Augmenting capital base for onward lending: 1988.00 1988.00 0
General Corporate Purposes: 673.15 673.15 0
Issue Related Expense: 38.39 38.39 0

Compliance Confirmation

The company has confirmed that there was no deviation in the objects or purposes for which the funds were raised, no deviation in the amount of funds actually utilised as against what was originally disclosed, and no change in the terms of any contract referred to in the Letter of Offer. The Audit Committee's comments and auditor remarks were noted as not applicable, given the absence of any deviation or variation.

The statement was signed by Manoj Shantilal Savla, Managing Director, and filed by Pinkal Mehta, Company Secretary and Compliance Officer (Membership No.: A59075). The aforesaid information is also available on the company's website at www.trustedgecapital.in .

Historical Stock Returns for Trustedge Capital

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%-4.55%+2.60%+80.46%+238.43%+3,231.33%

How will the Rs. 1988 lakhs deployed for onward lending impact Trustedge Capital's loan book growth and net interest margins in the coming quarters?

What strategic rationale drove Adinath Exim Resources to rebrand as Trustedge Capital, and does this signal a broader pivot toward becoming a full-fledged NBFC?

Given the complete utilisation of Rights Issue proceeds by March 2026, is the company likely to pursue additional capital-raising rounds to sustain its lending growth momentum?

More News on Trustedge Capital

1 Year Returns:+238.43%